Evio Pharmacy announces roll-out of biosimilar strategy

Mar 15, 2022

Evio Pharmacy announced a roll-out of a biosimilar strategy to help make medicines affordable.  Evio announced that it has contracted directly with biosimilars manufacturers for autoimmune disease and cancer therapeutics.

Print Page Mail Article